Astrazeneca Pharma India Ltd

Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2025.We would also like to inform you that the Trading Window remains closed for all Designated Persons from June 16 2025 to August 16 2025 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.